Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Effects of dietary phosphate on exercise and body fat

Official title: Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity

Run by University of Texas Southwestern Medical Center · NCT05147909 · Data updated 2026-11-12

This study is testing if eating less phosphate can help healthy adults exercise better and manage their body fat more effectively.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment124 (estimated)
SponsorUniversity of Texas Southwestern Medical Center
Academic / other
Locations1 site (Dallas, Texas)
StatusRecruiting
StartedSeptember 14, 2022
Main results expectedMarch 31, 2027
Study endsMarch 30, 2028
Registry record updatedFebruary 17, 2026
Trial IDNCT05147909 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are otherwise healthy adults without chronic diseases or conditions that affect exercise capacity.

Probably not a fit

Patients with chronic kidney disease, diabetes, or cardiovascular diseases are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how reducing dietary phosphate intake affects exercise capacity and fat distribution in healthy adults. Participants will undergo a randomized, crossover design where they will alternate between a high phosphate diet and a low phosphate diet over an 8-week period. The study will measure changes in skeletal muscle ATP synthesis and oxygen uptake during exercise testing, while also monitoring dietary phosphate intake through a dietary assessment tool. The goal is to determine if lowering phosphate intake can improve physical activity levels and metabolic health.

Why it matters

Potential benefit: If successful, this study could lead to dietary recommendations that enhance exercise capacity and reduce visceral fat in the general population.

How similar studies have gone: While studies in animal models have shown promising results, the relevance of these findings in humans remains largely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

The randomized crossover trial will be performed in on otherwise healthy subjects without diabetes mellitus, chronic kidney disease (CKD), preexisting cardiovascular disease or treatment with any vasoactive agent that might alter cardiovascular responses to exercise.

Exclusion Criteria:

1. history of cardiopulmonary disease or chronic kidney disease,
2. treatment with antihypertensive medications,
3. estimated glomerular filtration rate (eGFR) \< 60 mL/min/1.73m2, (4) diabetes mellitus or other systemic illness,

(5) pregnancy, (6) hypersensitivity to sodium phosphate, (7) any history of substance abuse or current cigarette use, (8) any history of psychiatric illness, (9) history of active malignancy, (10) serum phosphorus \< 2.4 or \> 4.5 mg/dL.

Where it's running

  • University of Texas Southwestern
    Dallas, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.